Rat bone-marrow colony-forming units in the spleen (CFUs-12) were found to lack the surface antigens recognized by the monoclonal antibodies CD53 (MRC-OX44), MRC-OX39, MRC-OX59, and 144.2.15. These would provide a strategy for their enrichment by depletion.
INTRODUCTION
It has long been known that fetal-liver stem cells differ from adult bone-marrow stem cells (Micklem and Loutit, 1966; Micklem et al., 1972; Hunt and Fowler, 1981) . In competitive repopulation experiments, the fetal-liver cells always made the major, and continuously increasing, contribution to the eventual phenotype, even with excess marrow cells (Micklem et al., 1972) . Therefore, there may be a surface antigenic distinction between these two cell types, because, whether the potency difference is intrinsic (reflecting a developmentally controlled genetic program) or extrinsic (for instance, homing to a particular microenvironment), it is likely to be manifest in a surface molecular difference. The use of cell-surface phenotype, as defined by monoclonal antibodies, has been the method most exploited to enrich pluripotent hemopoietic stem cells. It has provided them virtually pure in the mouse and human and helped to define stem-cell heterogeneity better (Spangrude et al., 1988; Szilvassy et al., 1989; Andrews et al., 1990; Terstappen et al., 1991;  Keller, 1992; Uchida et al., 1993; Spangrude, 1994 (Hunt, 1979; Jefferies et al., 1985a) , and in the adult. At day 14, promyelocytes and prolymphocytes are not yet evident. To define enrichment of stem-cell activity, potency in two respects must be measured: (1) self-renewal and (2) ability to repopulate all hemopoietic compartments. As others have emphasized (Harrison, 1980; Jordon et al., 1990; Keller and Snodgrass, 1990), in vivo long-term repopulation assays satisfy these criteria best. We have used a refinement of the Hunt and Fowler (1981) long-term reconstitution assay in irradiated rats, using two strains as cell host and donor that are congenic for an allelomorphic variant of the rat RT7 (CD45 equivalent) surface antigen (Newton et al., 1986) . CD45 is expressed on virtually all hemopoietic cells, so that in the various lympho-myeloid subsets, host-type and donor-type progeny can be distinguished by two-color flow cytometry. By determining chimaerism by registering the allelic phenotype of individual cells, rather than that of populations of cells as is necessary for enzyme polymorphic markers (e.g., Harrison, 1980; Flake et al., 1986) or retroviral integration, sites (Dick et al., 1985; Lemischka et al., 1986) proportion of fetal-liver cells that contained all totipotent stem-cell activity. This would maximize enrichment of activity. We knew that all such activity in collagenase-digested single-cell suspensions of day-17 liver was in the Transferrin-receptor negative (OX26-= CD71-) (Jefferies et al., 1985a) and Thy-l-positive (OX7 --CDw90 /) (Hunt, 1979) fraction. One aim of the present paper was to investigate whether this was true also of day-14 liver. In the next step, another mAb was selected from a panel of 36, which were more or less well characterized against rat lympho-hemopoietic cellsurface antigens. This picked out a subset of OX26-negative day-14 liver cells and was also shown to react on "stem cells" when screened in a standard bone-marrow colony-forming-unit assay (fetal liver would have been preferred, but it does not form spleen colonies in rats). The single mAb selected for further analysis of the fetal-liver stem-cell phenotype was MRC-OX82, originally described as staining myeloid cells (Highnam, unpublished) . Stemcell (Goldschneider et al., 1978; Hunt, 1979; Berman and Basch, 1985) , making it a logical choice to use in association with other mAbs in stem-cell p.urifications. Here we demonstrate, by the most reliable assay available for stem cells, namely, long-term repopulation, for the first time that this molecule is also expressed on primitive stem cells from day-14 fetal liver in rats.
Purification of stem cells form mouse bone marrow indicated that these had a low expression of the Thy-1 molecule (Spangrude et al., 1988) .
It might be fruitful to explore in a three-color system whether the OX7 /OX82 /OX26-population can be further subdivided. Possible candidates suggest themselves from the present studies. Of the other mAbs we tested that stain a minor subpopulation of OX26-a fetal liver, OX44 (Paterson et al., 1987a) stains the rat equivalent of the membrane transport protein CD53 (Amiot, 1990; Angelisov/ et al., 1990) . It was absent from the bone-marrow CFU-S population, though the balance sheet for this sort left some CFUs unaccounted for, so a proportion of marrow stem cells may bear OX44 antigen. MHC Class molecules have been described by others to be present on murine hemopoietic stem cells (van den Engh et al., 1980; Visser et al., 1984) , and although we showed here the presence of Class (as defined by the mAb OX27) on rat bone-marrow CFU-S (Table 1) , several attempts to extend this to long-term reconstituting stem cells from rat fetal liver gave equivocal results (data not shown).
Hemopoietic stem cells derived from fetal liver have long been known to be intrinsically different from their adult bone-marrow counterparts. Till et al. (1964) showed that fetal liver could give rise to CFUs with a seemingly unlimited potential for sequential transplantation into new recipients, whereas bone-marrow-derived CFUs were only transplantable a few times until no new CFUs were seen. In addition, fetal-liver-derived CFUs appeared to contain a higher proportion of morphologically undifferentiated cells. Subsequent studies looking at competitive repopulation of irradiated recipients by bone-marrow and fetal-liver cells similarly showed a predominance of the latter to reconstitute the hemopoietic compartment (Micklem and Loutit, 1966; Micklem et al., 1972; Hunt and Fowler, 1981) . The reasons for these results are unclear, but it has been suggested that the more primitive the state of stem cells, the higher is their potential for self-renewal (consistent with this, yolk sac cells can be serially transplanted for longer than fetal-liver cells; Metcalf and Moore, 1971) . It is also possible that the fetal stem cells have a superior ability to home to the appropriate hemopoietic microenvironment. The experiments described here confirm these findings, in that a dose of undepleted fetal-liver cells containing 10 times fewer cells than a dose of bone marrow injected at the same time repopulated up to 80% of the hemopoietic compartment after 3 months, and that this remained constant for more than a year. Our purification of fetal-liver stem cells at a very early stage of development should assist in characterizing their developmental programming.
MATERIALS AND METHODS

Animals
PVG RT7 rats were bred under specific pathogenfree conditions in the MRC Cellular Immunology Unit, and maintained in a "clean" room (fed on irradiated meal and acidified water, and air supply filtered). Congenic PVG RT7 b rats were bred and maintained under conventional conditions. This strain was obtained by backcrossing the RT7 b allele (as identified by a polyclonal antiserum; Fabre and Morris, 1974) to PVG inbred rats (RT7a) for twelve generations (Bell et al., 1989 (Paterson et al., 1987b), W3/15 (glycophorin; Hunt, unpublished) , W3/25 (CD4) (both Williams et al., 1977 (Goldschneider et al., 1986 ). UB11 and UB12 were a gift from Dr. T. Fukumoto (Fujikara et al., 1985 (Hunt, 1986) 
